Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
- Type
- Correction
- Notice date
- 6/2/2021 0:00
- Journal
- Frontiers in Oncology
- Publisher
- Frontiers
- Notice DOI
- 10.3389/fonc.2021.687841
- Original paper DOI
- 10.3389/fonc.2020.588533